Reginald Scott Widemon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Reginald Scott Widemon has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Akhilesh Keshav Sista
Department of Radiology, Weill Cornell Medicine, New York, New York
1 shared publication Angela Lignelli
Department of Radiology, Columbia University Irving Medical Center, New York, NY, USA
1 shared publicationChristopher W. Root
Icahn School of Medicine at Mount Sinai, New York, NY, USA
1 shared publication- James M. Horowitz
New York University Langone Health
1 shared publication Kathleen M Capaccione
Department of Radiology, Columbia University Irving Medical Center, New York, NY, USA
1 shared publication- Ken Zhao
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
1 shared publication
Latest Publications
- 3 May 2022
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 35 (6) , 713-717
The impact of the COVID-19 pandemic on neuroimaging volume in New York City
Background and Purpose: The COVID-19 pandemic acutely disrupted all facets of healthcare, with future implications that are expected to resonate for many years. We investigated the effect of the pandemic on neuroimaging volume, hypothesizing that all representative studies would experience a reduction in volume, with those typically performed in the inpatient setting (noncontrast enhanced CT head and CTA head/neck) taking longer to recover to pre-pandemic volumes compared to studies typically performed in the outpatient setting (MR brain with and without and MR lumbar spine without). Materials and Methods: We retrospectively queried our institution’s radiology reporting system to collect weekly data for 1 year following the World Health Organization declaration of a pandemic (11 March 2020–9 March 2021) and compared them to imaging volumes from the previous year (11 March 2019–9 March 2020). We subsequently analyzed quarterly data (e.g., first quarter comparison: 3/11/2020–6/9/2020 was compared to 3/11/2019–6/9/2019). Results: All studies experienced decreased volume during the first quarter of the year following onset of the COVID-19 pandemic, with noncontrast enhanced CT head failing to recover to pre-pandemic volumes. CTA head/neck actually surpassed pre-pandemic volume by the second quarter of the year. MRI brain w/wo and MRI lumbar spine without recovered to baseline volume by the second quarter. Conclusion: Noncontrast enhanced CT head did not recover pre-pandemic imaging volume. CTA head/neck volume initially decreased, however volume increased above pre-pandemic levels during the second quarter; this finding may be attributable to a prothrombotic state in COVID-19 patients.
- 3 May 2022
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 35 (6) , 713-717
The impact of the COVID-19 pandemic on neuroimaging volume in New York City
Background and Purpose: The COVID-19 pandemic acutely disrupted all facets of healthcare, with future implications that are expected to resonate for many years. We investigated the effect of the pandemic on neuroimaging volume, hypothesizing that all representative studies would experience a reduction in volume, with those typically performed in the inpatient setting (noncontrast enhanced CT head and CTA head/neck) taking longer to recover to pre-pandemic volumes compared to studies typically performed in the outpatient setting (MR brain with and without and MR lumbar spine without). Materials and Methods: We retrospectively queried our institution’s radiology reporting system to collect weekly data for 1 year following the World Health Organization declaration of a pandemic (11 March 2020–9 March 2021) and compared them to imaging volumes from the previous year (11 March 2019–9 March 2020). We subsequently analyzed quarterly data (e.g., first quarter comparison: 3/11/2020–6/9/2020 was compared to 3/11/2019–6/9/2019). Results: All studies experienced decreased volume during the first quarter of the year following onset of the COVID-19 pandemic, with noncontrast enhanced CT head failing to recover to pre-pandemic volumes. CTA head/neck actually surpassed pre-pandemic volume by the second quarter of the year. MRI brain w/wo and MRI lumbar spine without recovered to baseline volume by the second quarter. Conclusion: Noncontrast enhanced CT head did not recover pre-pandemic imaging volume. CTA head/neck volume initially decreased, however volume increased above pre-pandemic levels during the second quarter; this finding may be attributable to a prothrombotic state in COVID-19 patients.
- Open Access
- 1 June 2018
- Published by AME Publishing Company in Cardiovascular Diagnosis and Therapy
- Vol. 8 (3) , 244-252
Acute pulmonary embolism: endovascular therapy
Pulmonary embolism (PE) is a leading cause of morbidity and mortality worldwide. PE is a complex disease with a highly variable presentation and the available treatment options for PE are expanding rapidly. Anticoagulation (AC), systemic lysis, surgery, and catheter-directed thrombolysis (CDT) play important roles in treating patients with PE. Thus, a multidisciplinary approach to diagnosis, risk stratification, and therapy is required to determine which treatment option is best for a given patient with this complex disease.
- 1 June 2018
- Published by AME Publishing Company in Cardiovascular Diagnosis and Therapy
- Vol. 8 (3) , 244-252
Open AccessAcute pulmonary embolism: endovascular therapy
Pulmonary embolism (PE) is a leading cause of morbidity and mortality worldwide. PE is a complex disease with a highly variable presentation and the available treatment options for PE are expanding rapidly. Anticoagulation (AC), systemic lysis, surgery, and catheter-directed thrombolysis (CDT) play important roles in treating patients with PE. Thus, a multidisciplinary approach to diagnosis, risk stratification, and therapy is required to determine which treatment option is best for a given patient with this complex disease.